REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline S.A.E. (Egypt)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Glaxosmithkline S.A.E. Profile Updated: February 06, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Glaxo Smith Kline, a member of Glaxo Group Limited of UK is a research-based pharmaceutical and healthcare company, engaged in the manufacturing, packaging, sale and distribution of pharmaceutical products. Also, the company is involved in the manufacturing and distributing of several licensed products by other companies. The company was incorporated in 1981 in Cairo and was listed on the Egyptian Stock Exchange in 1985. The company's product portfolio includes treatments for complex diseases, such as asthma, malaria, depression, migraine, diabetes, heart failure, digestive conditions and cancer.

Legal Address
Boomerang Building,No 46, Block (J) First Section City Centre,Fifth District
Cairo; Greater Cairo; Postal Code: 11835

Contact Details: Purchase the Glaxosmithkline S.A.E. report to view the information.

Website: http://www.gsk.com

Basic Information
Total Employees:
Purchase the Glaxosmithkline S.A.E. report to view the information.
Outstanding Shares:
Purchase the Glaxosmithkline S.A.E. report to view the information.
Registered Capital:
Purchase the Glaxosmithkline S.A.E. report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline S.A.E. report to view the information.
Ratings:
Purchase the Glaxosmithkline S.A.E. report to view the information.
Incorporation Date:
1981
Key Executives
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
5.89%
Subsidiaries
Company Performance
Financial values in the chart are available after Glaxosmithkline S.A.E. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
-18.49%
Total operating revenue
-18.07%
Operating profit (EBIT)
-57.65%
EBITDA
-46.45%
Net Profit (Loss) for the Period
-30.86%
Total assets
-0.35%
Total equity
-1%
Operating Profit Margin (ROS)
-10.48%
Net Profit Margin
-1.08%
Return on Equity (ROE)
-2.37%
Debt to Equity Ratio
1.46%
Quick Ratio
-0.22%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?